Prevalence, Treatment, and Prognosis of Tumor Thrombi in Renal Cell Carcinoma.

Autor: Kaptein FHJ; Department of Medicine-Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands., van der Hulle T; Department of Medicine-Oncology, Leiden University Medical Center, Leiden, the Netherlands., Braken SJE; Department of Medicine-Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands., van Gennep EJ; Department of Urology, Leiden University Medical Center, Leiden, the Netherlands., Buijs JT; Department of Medicine-Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands., Burgmans MC; Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands., Cannegieter SC; Department of Medicine-Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands.; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands., du Chatinier EME; Department of Medicine-Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands., Huisman MV; Department of Medicine-Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands., van Persijn van Meerten EL; Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands., Versteeg HH; Department of Medicine-Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands., Pelger RCM; Department of Urology, Leiden University Medical Center, Leiden, the Netherlands., Klok FA; Department of Medicine-Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands.

Publikováno v: JACC. CardioOncology [JACC CardioOncol] 2022 Nov 15; Vol. 4 (4), pp. 522-531. Date of Electronic Publication: 2022 Nov 15 (Print Publication: 2022).